Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method

Authors:

Abstract
No abstract available
Funding Information
  • Novartis Pharmaceuticals Corporation

This publication has 45 references indexed in Scilit: